StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.68−0.02 (-1.18%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

Artelo Biosciences total assets

Total assets on the balance sheet at the end of each period.

Artelo Biosciences's total assets was $6.46M at Jun 30, 2026. For fiscal 2025 it was $2.80M, down 40.4% from the year before. Over ten years it grew 69.0% a year on average. The highest annual figure on record is $13.04M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.80M-40.4%
FY2024Dec 31, 2024$4.70M-64.0%
FY2023Dec 31, 2023$13.04M+3.2%
FY2021Aug 31, 2021$12.64M+188.7%
FY2020Aug 31, 2020$4.38M-32.5%
FY2019Aug 31, 2019$6.48M+1532.9%
FY2018Aug 31, 2018$397.00K-30.9%
FY2017Aug 31, 2017$574.28K+15896.5%
FY2016Aug 31, 2016$3.59K-78.9%
FY2015Aug 31, 2015$17.03K+15.6%
FY2014Aug 31, 2014$14.73K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$6.46M+48.2%
Q1 FY2026CQ1 2026Mar 31, 2026$12.52M+256.1%
Q4 FY2025CQ4 2025Dec 31, 2025$2.80M-40.4%
Q3 FY2025CQ3 2025Sep 30, 2025$4.27M-40.2%
Q2 FY2025CQ2 2025Jun 30, 2025$4.36M-47.7%
Q1 FY2025CQ1 2025Mar 31, 2025$3.52M-66.1%
Q4 FY2024CQ4 2024Dec 31, 2024$4.70M-64.0%
Q3 FY2024CQ3 2024Sep 30, 2024$7.14M-54.0%
Q2 FY2024CQ2 2024Jun 30, 2024$8.33M-50.7%
Q1 FY2024CQ1 2024Mar 31, 2024$10.35M-44.0%
Q4 FY2023CQ4 2023Dec 31, 2023$13.04M+3.2%
Q3 FY2023CQ3 2023Sep 30, 2023$15.50M+25.6%
Q2 FY2023CQ2 2023Jun 30, 2023$16.88M+25.5%
Q1 FY2023CQ1 2023Mar 31, 2023$18.48M+93.7%
Q4 FY2021CQ3 2021Aug 31, 2021$12.64M+188.7%
Q3 FY2021CQ2 2021May 31, 2021$12.34M+253.2%
Q2 FY2021CQ1 2021Feb 28, 2021$13.44M+223.8%
Q1 FY2021CQ4 2020Nov 30, 2020$9.54M+71.9%
Q4 FY2020CQ3 2020Aug 31, 2020$4.38M-32.5%
Q3 FY2020CQ2 2020May 31, 2020$3.49M+202.9%
Q2 FY2020CQ1 2020Feb 29, 2020$4.15M+757.4%
Q1 FY2020CQ4 2019Nov 30, 2019$5.55M+3255.0%
Q4 FY2019CQ3 2019Aug 31, 2019$6.48M+1532.9%
Q3 FY2019CQ2 2019May 31, 2019$1.15M+187.6%
Q2 FY2019CQ1 2019Feb 28, 2019$484.28K-10.5%
Q1 FY2019CQ4 2018Nov 30, 2018$165.36K-61.6%
Q4 FY2018CQ3 2018Aug 31, 2018$397.00K-30.9%
Q3 FY2018CQ2 2018May 31, 2018$400.98K+76.0%
Q2 FY2018CQ1 2018Feb 28, 2018$541.10K+3920.9%
Q1 FY2018CQ4 2017Nov 30, 2017$430.29K+11885.7%
Q4 FY2017CQ3 2017Aug 31, 2017$574.28K+15896.5%
Q3 FY2017CQ2 2017May 31, 2017$227.84K+6246.5%
Q2 FY2017CQ1 2017Feb 28, 2017$13.46K+274.8%
Q1 FY2017CQ4 2016Nov 30, 2016$3.59K-9.6%
Q4 FY2016CQ3 2016Aug 31, 2016$3.59K-78.9%
Q3 FY2016CQ2 2016May 31, 2016$3.59K-71.5%
Q2 FY2016CQ1 2016Feb 29, 2016$3.59K–
Q1 FY2016CQ4 2015Nov 30, 2015$3.97K–
Q4 FY2015CQ3 2015Aug 31, 2015$17.03K–
Q3 FY2015CQ2 2015May 31, 2015$12.58K–

More Artelo Biosciences figures

See a number that looks wrong?